Plasmodium berghei: In vitro and in vivo activity of dequalinium

Experimental Parasitology

Volumn 115, Issue 1, 2007, Pages 19-24

  Rodrigues, Juan Ricardo ^a   Gamboa de Domínguez, Neira ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Hematin; Bisquinolines; chloroquine; CQ; dequalinium; dimethyl sulfoxide; DMSO; DQ; Globin; glutathione; GSH; Heme; LEP; leupeptin; Malaria; P. berghei; PBS; PEP; pepstatin; phosphate buffered saline; Plasmodium berghei; RBC; red blood cells; SDS PAGE; sodium dodecyl sulfate polyacrylamide gel electrophoresis

Indexed keywords

CHLOROQUINE; DEQUALINIUM; GLOBIN; HEMATIN; HEMOGLOBIN; LEUPEPTIN; PEPSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SURVIVAL RATE;

ANIMALS; ANTI-INFECTIVE AGENTS; COLORIMETRY; DEQUALINIUM; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLOBINS; HEMEPROTEINS; MALARIA; MALE; MICE; PARASITEMIA; PLASMODIUM BERGHEI;

MURINAE; PLASMODIUM BERGHEI; PLASMODIUM PARASITES;

EID: 33751272427     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2006.05.002     Document Type: Article

References (41)

1. Adams P.A., Egan T.J., Silver J., and Marsh P.J. The chemical mechanism of β-hematin formation studied by Mossbauer spectroscopy. Biochemical Journal 318 (1996) 25-27
2. Ashley E.A., McGready R., Hutagalung R., Phaiphun L., Slight T., Proux S., Thwai K.L., Barends M., Looareesuwan S., White N.J., and Nosten F. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clinical Infectious Diseases 41 (2005) 425-432
3. Baelmans R., Deharo E., Muñoz V., Sauvain M., and Ginsburg H. Experimental conditions for testing the inhibitory activity of chloroquine on the formation of beta-hematin. Experimental Parasitology 96 (2000) 243-248
4. Basco L.K., Anderson S.L., Milhous W.K., and Vennerstrom J. in vitro activity of Bisquinoline WR 268, 668 against African clones and isolates of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 50 (1994) 200-205
5. Blauer G., and Akkawi M. Investigations of B- and β-hematin. Journal of Inorganic Biochemistry 66 (1997) 145-152
6. Bohle D., Dinnebier R.E., Madsen S.K., and Stephens P.W. Characterisation of the products of the heme detoxification pathway in malarial late trophozoites by X-ray diffraction. Journal of Biological Chemistry 272 (1997) 713-716
7. Coles R.B., Grubb C., Mathuran-Ayagam D., and Wilkinson D.S. Trial of dequalinium for skin infections. British Medical Journal 14 (1958) 1014-1016
8. Davis T.M., Hung T.Y., Sim I.K., Karunajeewa H.A., and Ilett K.F. Piperaquine: a resurgent antimalarial drug. Drugs 65 (2005) 75-87
9. Deharo E., Gautret P.H., Ginsburg H., Chabaud A.G., and Landau I. Synchronization of Plasmodium yoelii nigeriensis and P. y. killicki infection in the mouse by means of Percoll-glucose gradient stage fractionation: determination of the duration of the schizogonic cycle. Parasitology Research 80 (1994) 159-164
10. Della Casa V., Noll H., Gonser S., Grob P., Graf F., and Pohlig G. Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections. Arzneimittelforschung 52 (2002) 699-705
11. Denis M.B., Davis T.M., Hewitt S., Incardona S., Nimol K., Fandeur T., Poravuth Y., Lim C., and Socheat D. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clinical Infectious Diseases 35 (2002) 1469-1476
12. Egan T.J., Ross D.C., and Adams P.A. Quinoline antimalarial drugs inhibit spontaneous formation of β-hematin (malaria pigment). FEBS Letters 352 (1994) 54-57
13. Fan B., Zhao W., Ma X., Huang Z., Wen Y., Yang J., and Yang Z. In vitro sensitivity of Plasmodium falciparum to chloroquine, piperaquine, pyronaridine and ertesunate in Yuxi prefecture of Yunnan province. Zhongguo Ji Sheng Chong Xue Yu Ji Shong Chong Bing Za Zhi 16 (1998) 460-462
14. Fitch C.D., Chevli R., Banyal H.S., Phillips G., Pfaller M.A., and Krogstad D.J. Lysis of Plasmodium falciparum by chloroquine ferriprotoporphyrin IX complex. Antimicrobial Agents and Chemotherapy 21 (1982) 819-822
15. Galeano, E., Nieto, E., García-Perez, A. I., Delgado, M. D., Pinilla, M., Sancho, P., 2005. Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines. Mitochondrial implication in cell death. Leukocyte Research, May 11 [Epub ahead of print].
16. Goldberg D.E., Slater A.F.G., Cerami A., and Henderson G.B. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proceedings of the National Academy of Sciences United States of America 87 (1990) 2931-2935
17. Goldberg D.E. Plasmodial hemoglobin degradation: and ordered pathway in a specialized organelle. Infectious Agents and Diseases 1 (1992) 207-211
18. Greenwod B., and Mutabingwa T. Malaria in 2002. Nature 415 (2002) 670-678
19. Guruswami M.N., and Thampai C.K. The local anesthetic action of dequalinium chloride. Indian Journal of Medical Sciences 21 (1967) 325-327
20. Hofheinz W., and Masciadri R. Bisquinolines for the treatment of malaria. Chemical Abstracts 124 (1996) 260861g
21. Kaufman A.Y. The use of dequalinium acetate as a disinfectant and chemotherapeutic agent in endodontics. Oral Surgery, Oral Medicine and Oral Pathology 51 (1981) 434-441
22. Levinson D.R. Dequalinium in the treatment of trichomoniasis in women. Practitioner 183 (1959) 195-197
23. Li Y., Hu Y., Huang H.Z., Zhu D.Q., Huang W.J., Wu D.L., and Qian Y.L. Hydroxypiperaquine in the treatment of falciparum malaria. Chinese Medical Journal 94 (1981) 301-302
24. Lin C., Feny-yi Q., and Yan-chang Z. Field observations on the antimalarial piperaquine. Chinese Medical Journal 95 (1982) 281-286
25. Lin C. Recent studies on the antimalarial efficacy of piperaquine and hydroxyl piperaquine. Chinese Medical Journal 104 (1991) 161-164
26. Makler, M. T., Dequalinum salts for the treatment of malaria. (Flow, Inc., USA). U.S. Patent 4,946,849, 7 August 1990.
27. Orijh A.U., and Fitch C.S. Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine. Biochimica and Biophysica Acta 1157 (1993) 270-274
28. Peters W. Drug resistance in malaria parasites of animals and man. Advances in Parasitology 41 (1998) 1-62
29. Peters W., and Robinson B.L. Parasitic infection models. In: Zak O., and Sande M. (Eds). Handbook of Animal Models of Infection (1999), Academic Press, London 757-773
30. Raynes K.J., Galatis D., Cowman A.F., Tilley L., and Deady L.W. Synthesis and activity of some antimalarial bisquinolines. Journal of Medicinal Chemistry 38 (1995) 204-206
31. Raynes K.J., Foley M., and Tilley L. Novel bisquinoline antimalarials, antimalarial activity and inhibition of heme polymerization. Molecular and Biochemical Parasitology 52 (1996) 551-559
32. Raynes K. Bisquinoline antimalarials: their role in malaria chemotherapy. International Journal of Parasitology 29 (1999) 367-379
33. Ridley R.G., Hofheinz W., Matile H., Jaquet C., Dorn A., Masciadri R., Jolidon S., Richter W.F., Guenzi A., Girometta M.A., Urwyler H., Huber W., Thaithong S., and Peters W. 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine resistant Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 40 (1996) 1846-1854
34. Ridley R.G., Matile H., Jaquet C., Dorn A., Hofheinz W., Leupin W., Masciadri R., Theil F.P., Richter W.F., Girometta M.A., Guenzi A., Urwyler H., Gocke E., Potthast J.M., Csato M., Thomas A., and Peters W. Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737. Antimicrobial Agents and Chemotherapy 41 (1997) 677-686
35. Rosenthal P.J. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Experimental Parasitology 80 (1995) 272-281
36. Slater A.F., Swiggard W.J., Orton B.R., Flitter W.D., Goldberg D.E., Cerami A., and Henderson G.B. An iron-carboxylate bond links the heme units of the malarial parasites pigment. Proceedings of the National Academy of Sciences United States of America 88 (1991) 325-329
37. Vennerstrom J., Ellis W.Y., Ager A.L., Anderson S.L., Gerena L., and Milhous W.K. Bisquinolines, N,N′-bis(7-chloroquinoline-4-yl) alkanediamines with potential against chloroquine resistant malaria. Journal of Medicinal Chemistry 35 (1992) 2129-2134
38. Viglioglia P.A. Trial of dequalinium in the treatment of superficial mycoses. Seminars in Medicine 120 (1962) 205-207
39. Weiss M.J., Wong J.R., Ha C.S., Bleday R., Salem R.R., Steele Jr. G.D., and Chen L.B. Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. Proceedings of the National Academy of Sciences United States of America 84 (1987) 5444-5448
40. Weekly Epidemiological Record, 1997. WHO 72 (No I, II, III), 269-292.
41. Zhu D.Q., Dai Z.R., Li J.C., and Jiang Z.K. Studies on piperaquine as long-acting antimalarial drug against Plasmodium berghei in mice. Yao Xue Xue Bao 17 (1982) 894-898